PHAT icon

Phathom Pharmaceuticals

84 hedge funds and large institutions have $820M invested in Phathom Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

3% less capital invested

Capital invested by funds: $843M → $820M (-$23.3M)

4% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 23

Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$523K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$13.5M
2 +$8.16M
3 +$7.09M
4
JP Morgan Chase
JP Morgan Chase
New York
+$5.03M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.95M

Top Sellers

1 -$1.96M
2 -$1.6M
3 -$1.42M
4
MWNA
Marshall Wace North America
New York
-$1.17M
5
Marshall Wace
Marshall Wace
United Kingdom
-$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$413K
52
$400K
53
$392K
54
$359K
55
$356K
56
$353K
57
$271K
58
$270K
59
$256K
60
$249K
61
$241K
62
$230K
63
$197K
64
$191K
65
$176K
66
$167K
67
$162K
68
$131K
69
$67K
70
$60K
71
$51K
72
$32K
73
$27K
74
$19K
75
$19K